NeuroMetrix (NURO) Reports Q3 Loss of $0.26/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/30/2026

1. INTC
2. AMZN
3. COIN
4. PINS
5. RDDT
6. SNDK
7. FSLR
8. DASH
9. FND
10. RBLX

Go back to NeuroMetrix (NURO) Reports Q3 Loss of $0.26/Share

NeuroMetrix Reports Q3 2015 Financial Results and Highlights

October 22, 2015 7:00 AM EDT

Approximately 4,500 Quell® Devices Shipped, Up 73% Compared to Q2 2015 DPNCheck® Shipments at Three Year High of Nearly 40,000 Biosensors Revenue Up 44% to $2.1 Million Compared to Q3 2014

WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO), today reported financial and business highlights for the quarter ended September 30, 2015.

The Company operates in two markets - wearable therapeutic technology and point-of-care diagnostic tests. Its newest product is Quell, an over-the-counter wearable therapeutic device for chronic pain that was launched during the second quarter of 2015. Its... More